WO2009048326A3 - Préparation pour le traitement d'une maladie pulmonaire - Google Patents

Préparation pour le traitement d'une maladie pulmonaire Download PDF

Info

Publication number
WO2009048326A3
WO2009048326A3 PCT/NL2008/050636 NL2008050636W WO2009048326A3 WO 2009048326 A3 WO2009048326 A3 WO 2009048326A3 NL 2008050636 W NL2008050636 W NL 2008050636W WO 2009048326 A3 WO2009048326 A3 WO 2009048326A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
treatment
pulmonary disease
extract
pulmonary
Prior art date
Application number
PCT/NL2008/050636
Other languages
English (en)
Other versions
WO2009048326A2 (fr
Inventor
Mohamed Abdeslam Yacobi
Original Assignee
Snp Bioscience B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL1034499A external-priority patent/NL1034499C1/nl
Application filed by Snp Bioscience B.V. filed Critical Snp Bioscience B.V.
Publication of WO2009048326A2 publication Critical patent/WO2009048326A2/fr
Publication of WO2009048326A3 publication Critical patent/WO2009048326A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une préparation phytothérapeutique pour une administration orale. La préparation comprend de préférence du miel, un vinaigre de cidre, du sel de mer, un extrait de Trigonella et un extrait de Nigella. L'invention concerne également la préparation pour une utilisation dans un traitement médical, en particulier pour une utilisation dans le traitement d'une maladie pulmonaire et/ou respiratoire.
PCT/NL2008/050636 2007-10-10 2008-10-06 Préparation pour le traitement d'une maladie pulmonaire WO2009048326A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL1034499A NL1034499C1 (nl) 2007-10-10 2007-10-10 Middel ter behandeling van aandoeningen aan de luchtwegen.
NL1034499 2007-10-10
EP08158980 2008-06-25
EP08158980.6 2008-06-25

Publications (2)

Publication Number Publication Date
WO2009048326A2 WO2009048326A2 (fr) 2009-04-16
WO2009048326A3 true WO2009048326A3 (fr) 2009-09-17

Family

ID=40549767

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2008/050636 WO2009048326A2 (fr) 2007-10-10 2008-10-06 Préparation pour le traitement d'une maladie pulmonaire

Country Status (1)

Country Link
WO (1) WO2009048326A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA35372B1 (fr) * 2013-01-28 2014-09-01 Univ Moulay Ismail Formulation avec ingredients naturels contre l'ashme la toux a un effet nettoyant pulmonaire pour les fumeurs
WO2017129198A1 (fr) * 2016-01-26 2017-08-03 أمل صدفي سعد على، Composition naturelle qui renforce le système immunitaire par activation des glandes pour résister aux virus, bactéries et autres microbes

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042834A (en) * 1997-01-29 2000-03-28 Baraka; Mohamed Wasif Herbal composition for diabetes and method of treatment
US20020061841A1 (en) * 1999-03-02 2002-05-23 Nassief Nida Abdul-Ghani Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils
JP2004115420A (ja) * 2002-09-25 2004-04-15 Herb Road Co 気管支及び肺疾患の治療剤及びそれを含有する飲食品
WO2005070440A1 (fr) * 2004-01-24 2005-08-04 Eman Gaber Haggag Formule a base d'herbes medicinales pour traiter l'asthme allergique (asthme chronique)
US20050214393A1 (en) * 2004-03-26 2005-09-29 Osama Kandil Lipid fraction of Nigella sativa L. seeds
CN1686243A (zh) * 2005-04-15 2005-10-26 刘高生 治疗慢性支气管炎的中药配方
CN101024014A (zh) * 2007-03-16 2007-08-29 邓丽菊 一种治疗咳喘的药物组合物及其制剂

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042834A (en) * 1997-01-29 2000-03-28 Baraka; Mohamed Wasif Herbal composition for diabetes and method of treatment
US20020061841A1 (en) * 1999-03-02 2002-05-23 Nassief Nida Abdul-Ghani Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils
EP1709995A1 (fr) * 1999-03-02 2006-10-11 Al-Jassim, Rawaa Traitement de l'asthme et de l'allergie utilisant nigella sativa
JP2004115420A (ja) * 2002-09-25 2004-04-15 Herb Road Co 気管支及び肺疾患の治療剤及びそれを含有する飲食品
WO2005070440A1 (fr) * 2004-01-24 2005-08-04 Eman Gaber Haggag Formule a base d'herbes medicinales pour traiter l'asthme allergique (asthme chronique)
US20050214393A1 (en) * 2004-03-26 2005-09-29 Osama Kandil Lipid fraction of Nigella sativa L. seeds
CN1686243A (zh) * 2005-04-15 2005-10-26 刘高生 治疗慢性支气管炎的中药配方
CN101024014A (zh) * 2007-03-16 2007-08-29 邓丽菊 一种治疗咳喘的药物组合物及其制剂

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
ALI BH, BLUNDEN G.: "Pharmacological and toxicological properties of Nigella sativa.", PHYTOTHER RES., vol. 17, no. 4, 2003, pages 299 - 305, XP002538026 *
ANONYMUS: "AM04/143 Vilvailaik Kudineer", INTERNET ARTICLE-TKDL DATABASE, 2009, India (Chennai), pages 1 - 3, XP002538020, Retrieved from the Internet <URL:http://www.tkdl.res.in/tkdl/LangDefault/common/TKDLSearch.asp?GL=Eng> [retrieved on 20090717] *
ANONYMUS: "AM04/143 Vilvailaik Kudineer", INTERNET ARTICLE-TKDL DATABASE, 2009, pages 1 - 3, XP002538022, Retrieved from the Internet <URL:http://www.tkdl.res.in/tkdl/LangDefault/common/TKDLSearch.asp?GL=Eng> [retrieved on 20090717] *
ANONYMUS: "AM05/184B Ganankalukku Maruthuvam-1", INTERNET-TKDL DATABASE, India (Chennai), pages 1 - 3, XP002538021, Retrieved from the Internet <URL:http://www.tkdl.res.in/tkdl/LangDefault/common/TKDLSearch.asp?GL=Eng> [retrieved on 20090717] *
ANONYMUS: "AM05/184N Ganankalukku Maruthuvam -10", INTERNET-TKDL DATABASE, 2009, India, pages 1 - 3, XP002538023, Retrieved from the Internet <URL:http://www.tkdl.res.in/tkdl/LangDefault/common/TKDLSearch.asp?GL=Eng> [retrieved on 20090717] *
BOSKABADI M.H.,SHIRMOHAMMADI B.: "EFFECT OF NIGELLA SATIVA ON ISOLATED GUINEA PIG TRACHEA", ARCHIVES OF IRANIAN MEDICINE, vol. 5, no. 2, 2002, pages 103 - 107, XP002538079 *
BOSKABADY MH, JAVAN H, SAJADY M, RAKHSHANDEH H.: "The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients.", FUNDAM CLIN PHARMACOL., vol. 21, no. 5, 2007, pages 559 - 566, XP002538024 *
DATABASE WPI Derwent World Patents Index; AN 2004310748, XP002538049 *
DATABASE WPI Derwent World Patents Index; AN 2006264483, XP002538048, "Chinese medicinal formula for treating bronchitis" *
DATABASE WPI Derwent World Patents Index; AN 2008-A82067, XP002538047, "A medicine compound and its preparation to treat cough and asthma" *
DUKE, A. ET AL.: "Handbook of medicinal herbs. 2nd edition-Pimpinella anisum", 2002, CRC PRESS, USA, XP002538027 *
DUKE, A. ET AL: "Handbook of medicinal herbs. 2nd edition-Foeniculum vulgare", 2002, CRC PRESS, USA, XP002538028 *
KALUS U, PRUSS A, BYSTRON J, JURECKA M, SMEKALOVA A, LICHIUS JJ, KIESEWETTER H: "Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases", PHYTOTHERAPY RESEARCH, vol. 17, 2005 - 1209, pages 1214, XP002538025 *

Also Published As

Publication number Publication date
WO2009048326A2 (fr) 2009-04-16

Similar Documents

Publication Publication Date Title
WO2007128817A3 (fr) Dérivé insulinique
WO2006060314A3 (fr) Generation de virus capables de replication a usage therapeutique
WO2006015035A8 (fr) Composés utiles pour l&#39;infection par hpv
IL205114A (en) Medical procedure with minimum invasive system for minimally invasive treatment of mitral valve failure
WO2010114824A8 (fr) Dérivés d&#39;azoanthracène substitués, compositions pharmaceutiques et leurs procédés d&#39;utilisation
CA2746228C (fr) Proteines f de vrs modifiees et leurs methodes d&#39;utilisation
WO2009108730A3 (fr) Formes de rifaximine et utilisations correspondantes
WO2009014781A3 (fr) Matériaux contenant du métal utilisés dans le traitement d&#39;affections bactériennes
EP1979269A4 (fr) Formulations de chlorite et leurs procédés de préparation et d&#39;utilisation
EP4215185A8 (fr) Procédé de préparation intestinale
WO2009004629A3 (fr) Procédé pour réduire les symptômes de consommation d&#39;alcool
WO2006137100A3 (fr) Complexe moleculaire comprenant de l&#39;arbutine, de l&#39;acide ascorbique, de l&#39;oleuropeine ou des derives de celle-ci et des utilisations relatives de celui-ci dans le domaine medical
WO2006091841A3 (fr) Compositions et leurs utilisations ciblees sur il 4r-$g(a)
WO2009099553A3 (fr) Utilisation d’inhibiteur de kinase pour le traitement de l’athérosclérose
ZA201007391B (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium in the blood
WO2008039941A3 (fr) Protéine scgb3a2 utilisée en tant que facteur de croissance et qu&#39;agent anti-apoptotique
WO2006047470A3 (fr) Compositions contenant un extrait de malva sylvestris et utilisation de ces compositions sur des tissus muqueux
WO2007025229A3 (fr) Compositions et utilisations contre hsp27
WO2009048326A3 (fr) Préparation pour le traitement d&#39;une maladie pulmonaire
EP1946639A3 (fr) DDGS en tant qu&#39;élément améliorant la saveur à faible coût et activateur de réduction de sodium
EP2716285A3 (fr) Nouveau procédé pour identifier des composés utiles pour le traitement et/ou la prévention de maladies liées à la perte osseuse
WO2011028799A3 (fr) Formulations transmuqueuses de gangliosides
IL206464A0 (en) Pharmaceutical composition, use of 2-imminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
WO2010032141A3 (fr) Vaccins contre haemophilus influenzae non typable et leurs utilisations
WO2005069735A3 (fr) Procedes therapeutiques et compositions pharmaceutiques destinees a traiter des verrues avec des compositions a base de tellure

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08837671

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08837671

Country of ref document: EP

Kind code of ref document: A2